Clinical Trial Update: Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease [Phase 1]

View source ↗

Summary

Phase 1 study comparing prasugrel and clopidogrel in patients with coronary artery disease across different body weights, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• EFFIENT (prasugrel hydrochloride)
• Plavix (clopidogrel)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Coronary Artery Disease | Phase 1 | Status: COMPLETED | Results posted: 2012-08-30